Kiora Pharmaceuticals (KPRX) Gains from Investment Securities (2015 - 2022)
Kiora Pharmaceuticals' (KPRX) quarterly Gains from Investment Securities came in at $1.4 million in Q3 2022, up 1995.55% YoY from $68006.0 in Q3 2021, and up 4225.96% on a QoQ basis from $32943.0 in Q2 2022.
Kiora Pharmaceuticals (KPRX) Gains from Investment Securities (2015 - 2022) Analysis & Trends
Kiora Pharmaceuticals (KPRX) has 3 years of Gains from Investment Securities data on file, last reported at $1.4 million in Q3 2022.
- Quarterly Gains from Investment Securities rose 1995.55% year-over-year to $1.4 million in Q3 2022, while the trailing twelve-month figure through Dec 2023 was $1.4 million (down 15.77% YoY) and the FY2022 annual result came in at $1.4 million, changed N/A from the prior year.
- Gains from Investment Securities grew to $1.4 million in Q3 2022, from $32943.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $1.4 million in Q3 2022 to a low of -$570203.0 in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Kiora Pharmaceuticals | 15.64 Mn | 15.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 1.43 Mn |
| Sep 30, 2022 | 1.43 Mn |
| Jun 30, 2022 | 32,943.00 |
| Jun 30, 2022 | 32,943.00 |
| Mar 31, 2022 | 233,890.00 |
| Mar 31, 2022 | 233,890.00 |
| Dec 31, 2021 | 428,480.00 |
| Dec 31, 2021 | 428,480.00 |
| Sep 30, 2021 | 68,006.00 |
| Sep 30, 2021 | 68,006.00 |
| Jun 30, 2021 | 73,717.00 |
| Jun 30, 2021 | 73,717.00 |
| Mar 31, 2021 | -570,203.00 |
| Mar 31, 2021 | -570,203.00 |
| Mar 31, 2015 | -223,172.00 |
| Mar 31, 2015 | -223,172.00 |